Nurse Practitioner, Psychiatric/Mental Health · Las Vegas, NV
NPI
1932241007
Since 2007
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1721 E Charleston Blvd
Las Vegas, NV, 89104
Phone (702) 515-9680
Medicare paid, 2024
$56K
769 services
Medicare patients, 2024
109
Average age 62
Drug cost, 2024
$480K
4,729 prescriptions
Company payments, 2025
$475
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Festus Ebonka was code 90833 (psychotherapy - nongroup), 273 times for 86 patients. In total Festus Ebonka billed 769 services in 19 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 273 | 86 | $46.74 | $13K |
| 99214 Office E&M - Established | Office | 258 | 80 | $81.19 | $21K |
| 90791 Psychotherapy - Nongroup | Office | 89 | 73 | $105.87 | $9,422 |
| 90839 Psychotherapy - Nongroup | Office | 26 | 20 | $88.24 | $2,294 |
| 99497 Care Management/Coordination | Office | 16 | 16 | $54.16 | $867 |
By year: 2022 $132K for 1,305 services; 2023 $81K for 1,164 services; 2024 $56K for 769 services.
Medicare prescription drug claims, 2024
In 2024, the drug Festus Ebonka prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 356 prescriptions and refills. In total Festus Ebonka wrote 4,729 Medicare prescriptions that cost $480K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 356 | 356 | 70 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 256 | 256 | 48 | $5,878 |
| Ibuprofen Generic | 204 | 205 | 42 | $1,636 |
| Amlodipine Besylate Generic | 175 | 260 | 53 | $287 |
| Alprazolam Generic | 154 | 154 | 31 | $717 |
| Tizanidine Hcl Generic | 145 | 145 | 34 | $993 |
| Atorvastatin Calcium Generic | 127 | 201 | 39 | $458 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 127 | 132 | 31 | $3,485 |
| Gabapentin Generic | 126 | 129 | 38 | $1,216 |
| Oxycodone Hcl Generic | 119 | 119 | 26 | $1,928 |
| Trazodone Hcl Generic | 103 | 103 | 21 | $775 |
| Metformin Hcl Generic | 100 | 139 | 28 | $219 |
| Lisinopril Generic | 94 | 140 | 32 | $282 |
| Chlorzoxazone Generic | 85 | 85 | 26 | $127K |
| Hydroxyzine Hcl Generic | 85 | 89 | 22 | $1,167 |
Brand drugs: 444 claims; generic drugs: 4,230 claims; opioid claims: 792.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Festus Ebonka $475 ($475 in general payments such as food, travel and fees) from 10 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $122.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $122 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $85.84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $49.56 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.37 |
| Forte Bio-Pharma LLC | 2 | $46.3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $29.45 |
| Alkermes, Inc. ALKS | 1 | $28.22 |
| Pfizer Inc. PFE | 1 | $27.08 |
| Abbvie Inc. ABBV | 1 | $20.49 |
| Lilly USA, LLC LLY | 1 | $18.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.